Varga J Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis. [Journal Article] Curr Rheumatol Rep 2003 Apr; 5(2):145-6. Full Citation | Publisher Full Text | Find Related Articles
Nielsen-Kudsk JE [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension] [Journal Article] Ugeskr Laeger 2003 Jul 14; 165(29):2891-4. Abstract | Full Citation | Find Related Articles
Musch A [Pulmonary arterial hypertension. Therapy with the endothelin-1 receptor antagonist bosentan] [Journal Article] Med Monatsschr Pharm 2006 Jul; 29(7):242-5. Abstract | Full Citation | Find Related Articles
[Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension] [Journal Article] MMW Fortschr Med 2004 Dec 9; 146(50):72-3. Full Citation | Publisher Full Text | Find Related Articles
Pittrow D, Kirch W Dual endothelin receptor antagonism in pulmonary arterial hypertension. [Editorial] Eur J Clin Invest 2006 Sep.:v-vi. Full Citation | Find Related Articles
Ahmadi-Simab K, Lamprecht P, Hellmisch B, et al. [Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience] [Journal Article] Z Rheumatol 2004 Dec; 63(6):495-7. Full Citation | Find Related Articles
Dupuis J Endothelin-receptor antagonists in pulmonary hypertension. [Comment, Journal Article] Lancet 2001 Oct 6; 358(9288):1113-4. Full Citation | Find Related Articles
Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo